The $5 Billion Opportunity For Sunshine Heart's C-Pulse Device Seeking Alpha Heartware's success can be a harbinger of things to come for Sunshine Heart (SSH), a company that also targets late-stage Congestive Heart Failure (CHF), albeit a far larger and untreated sub-segment, as we'll look at in this article. Unmet Need in ... |
